{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:28:55Z","timestamp":1791343735711,"version":"4.3.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["296306"],"award-info":[{"award-number":["296306"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101757","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T11:39:59Z","timestamp":1733139599000},"page":"101757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019"],"prefix":"10.1016","volume":"30","author":[{"given":"Jacob","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2515-5903","authenticated-orcid":false,"given":"Jessica","family":"Burnside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alnoor","family":"Ramji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.aohep.2024.101757_bib0001","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11886-024-02025-6","article-title":"The global epidemic of metabolic fatty liver disease","volume":"26","author":"Lee","year":"2024","journal-title":"Curr Cardiol Rep"},{"issue":"9","key":"10.1016\/j.aohep.2024.101757_bib0002","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101757_bib0003","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2024.101757_bib0004","first-page":"167","article-title":"Pathogenesis and prevention of hepatic steatosis","volume":"11","author":"Nassir","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"3","key":"10.1016\/j.aohep.2024.101757_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.aohep.2024.101757_bib0006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.aohep.2024.101757_bib0007","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41598-022-05492-5","article-title":"Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication","volume":"12","author":"Nakai","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.aohep.2024.101757_bib0008","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00432-024-05708-3","article-title":"Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma","volume":"150","author":"Schrecker","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101757_bib0009","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.9778\/cmajo.20190212","article-title":"Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study","volume":"8","author":"Swain","year":"2020","journal-title":"CMAJ Open"},{"issue":"3","key":"10.1016\/j.aohep.2024.101757_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"Suppl","key":"10.1016\/j.aohep.2024.101757_bib0011","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.3350\/cmh.2022.0392","article-title":"Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management","volume":"29","author":"Battistella","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101757_bib0012","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101757_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101154","article-title":"Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: an updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018","volume":"29","author":"Wang","year":"2024","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101757_bib0014","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101757_bib0015","series-title":"Canadian health measures survey (CHMS)","year":"2024"},{"issue":"7","key":"10.1016\/j.aohep.2024.101757_bib0016","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/dc14-2474","article-title":"Prevalence of prediabetes and undiagnosed diabetes in Canada (2007-2011) according to fasting plasma glucose and HbA1c screening criteria","volume":"38","author":"Rosella","year":"2015","journal-title":"Diabet Care"},{"issue":"7","key":"10.1016\/j.aohep.2024.101757_bib0017","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.aohep.2024.101757_bib0018","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cgh.2020.11.028","article-title":"Agreement between the prevalence of nonalcoholic fatty liver disease determined by transient elastography and fatty liver indices","volume":"20","author":"Jones","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101757_bib0019","article-title":"Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications","volume":"8","author":"Ciardullo","year":"2020","journal-title":"BMJ Open Diabet Res Care"},{"issue":"4","key":"10.1016\/j.aohep.2024.101757_bib0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.14172","article-title":"Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population","volume":"46","author":"Yip","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.aohep.2024.101757_bib0021","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/00365521.2021.1984572","article-title":"Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care","volume":"57","author":"Bergram","year":"2022","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"10.1016\/j.aohep.2024.101757_bib0022","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101757_bib0023","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2024.101757_bib0024","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101757_bib0025","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101757_bib0026","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MCG.0000000000001585","article-title":"Identifying patients at risk for fibrosis in a primary care NAFLD cohort","volume":"57","author":"Schreiner","year":"2023","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl","key":"10.1016\/j.aohep.2024.101757_bib0027","first-page":"37","article-title":"Canadian Health Measures Survey: ethical, legal and social issues","volume":"18","author":"Day","year":"2007","journal-title":"Health Rep"},{"issue":"2","key":"10.1016\/j.aohep.2024.101757_bib0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12072-018-09926-z","article-title":"Race\/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016","volume":"13","author":"Kim","year":"2019","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.aohep.2024.101757_bib0029","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.gastro.2020.04.048","article-title":"Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study","volume":"159","author":"Nabi","year":"2020","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.aohep.2024.101757_bib0030","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jgh.16314","article-title":"Non-alcoholic fatty liver disease prevalence in Australia has risen over 15 years in conjunction with increased prevalence of obesity and reduction in healthy lifestyle","volume":"38","author":"Vaz","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101757_bib0031","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.aohep.2020.01.003","article-title":"Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?","volume":"19","author":"Garc\u00eda-Compe\u00e1n","year":"2020","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101757_bib0032","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3350\/cmh.2019.0065","article-title":"Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017","volume":"26","author":"Park","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.aohep.2024.101757_bib0033","first-page":"270","article-title":"Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes","volume":"37","author":"Fennoun","year":"2020","journal-title":"Pan Afr Med J"},{"issue":"6","key":"10.1016\/j.aohep.2024.101757_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2023.108475","article-title":"Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study","volume":"37","author":"Corbin","year":"2023","journal-title":"J Diabet Complicat"},{"issue":"7","key":"10.1016\/j.aohep.2024.101757_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12070664","article-title":"Comparison of the diagnostic performance of steatosis indices for discrimination of CT-diagnosed metabolic dysfunction-associated fatty liver disease","volume":"12","author":"Han","year":"2022","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.aohep.2024.101757_bib0036","doi-asserted-by":"crossref","first-page":"164","DOI":"10.21037\/hbsn.2018.12.04","article-title":"Nonalcoholic fatty liver disease: does sex matter?","volume":"8","author":"Lonardo","year":"2019","journal-title":"Hepatobil Surg Nutr"},{"issue":"6","key":"10.1016\/j.aohep.2024.101757_bib0037","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"issue":"11","key":"10.1016\/j.aohep.2024.101757_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141691","article-title":"Age- and gender dependent liver fat content in a healthy normal BMI population as quantified by fat-water separating DIXON MR imaging","volume":"10","author":"Ulbrich","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.aohep.2024.101757_bib0039","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2024.101757_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12955-016-0420-z","article-title":"Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)","volume":"14","author":"Golabi","year":"2016","journal-title":"Health Qual Life Outcome"},{"issue":"6","key":"10.1016\/j.aohep.2024.101757_bib0041","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.aohep.2024.101757_bib0042","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-021-00477-7","article-title":"Defining comprehensive models of care for NAFLD","volume":"18","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101757_bib0043","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2023.04.035","article-title":"A global research priority agenda to advance public health responses to fatty liver disease","volume":"79","author":"Lazarus","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101757_bib0044","series-title":"Pediatric non-alcoholic fatty liver disease (NAFLD) primary care pathway","year":"2024"},{"issue":"4","key":"10.1016\/j.aohep.2024.101757_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3138\/canlivj-2023-0010","article-title":"Geographic disparities in gastroenterologists and transient elastography across Canada","volume":"6","author":"Burnside","year":"2023","journal-title":"Can Liver J"},{"issue":"2","key":"10.1016\/j.aohep.2024.101757_bib0045","article-title":"Limitations of non-invasive tests for assessment of liver fibrosis","volume":"2","author":"Patel","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.aohep.2024.101757_bib0046","article-title":"AASLD Practice Guideline on blood-based non-invasive liver disease assessments of hepatic fibrosis and steatosis","author":"Sterling","year":"2024","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.aohep.2024.101757_bib0047","article-title":"Accuracy of noninvasive diagnostic tests for the detection of significant and advanced fibrosis stages in nonalcoholic fatty liver disease: a systematic literature review of the US studies","volume":"12","author":"Gosalia","year":"2022","journal-title":"Diagnost (Basel)"},{"key":"10.1016\/j.aohep.2024.101757_bib0048","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/tgh.2019.11.14","article-title":"Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease","volume":"5","author":"Altamirano","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101757_bib0049","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101757_bib0050","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/liv.14908","article-title":"Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: a systematic review","volume":"41","author":"Draijer","year":"2021","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.aohep.2024.101757_bib0051","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.aohep.2024.101757_bib0052","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/apt.14234","article-title":"Editorial: progress towards a simple tool for screening for hepatic steatosis in the general population - authors' reply","volume":"46","author":"Yip","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2024.101757_bib0053","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clinbiochem.2018.12.003","article-title":"The potential of reducing AST testing in hospital settings","volume":"64","author":"Ivica","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.aohep.2024.101757_bib0054","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clinbiochem.2020.02.006","article-title":"Defining appropriate utilization of AST testing","volume":"79","author":"Mohammed-Ali","year":"2020","journal-title":"Clin Biochem"},{"key":"10.1016\/j.aohep.2024.101757_bib0055","series-title":"Diabetes among canadian adults","year":"2023"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:32:19Z","timestamp":1777782739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124005404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268124005404"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101757","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101757"}}